To determine the methylation status of the CHL1 gene, three CpG sites in its promoter were pyrosequenced in a series of 142 breast tumours, 45 paired tumour and adjacent-to-tumour tissues, and 19 non-neoplastic breast tissues from reduction mammoplasties (Supplementary Figure 1). Here, CHL1 is linked to neoplasm.